Market capitalization | €853.58m |
Enterprise Value | €930.55m |
PER (TTM) P/E ratio | 8.50 |
EV/FCF (TTM) EV/FCF | 5.49 |
EV/Sales (TTM) EV/Sales | 0.28 |
P/S ratio (TTM) P/S ratio | 0.25 |
P/B ratio (TTM) P/B ratio | 0.60 |
Dividend yield | 3.82% |
Last dividend (FY23) | €1.74 |
As a Free StocksGuide user, you can view scores for all 6,945 stocks worldwide.
5 Analysts have issued a Draegerwerk forecast:
5 Analysts have issued a Draegerwerk forecast:
Mar '24 |
+/-
%
|
||
Revenue | 3,348 3,348 |
2%
2%
|
|
Gross Profit | 1,451 1,451 |
11%
11%
|
|
EBITDA | 313 313 |
144%
144%
|
EBIT (Operating Income) EBIT | 167 167 |
115%
115%
|
Net Profit | 100 100 |
141%
141%
|
In millions EUR.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Drägerwerk AG & Co. KGaA engages in the provision of medical and safety technology products. It operates through the following geographical segments: Europe; Americas; and Africa, Asia & Australia. The company was founded by Johann Heinrich Draeger in 1889 and is headquartered in Luebeck, Germany.
Head office | Germany |
CEO | Stefan Dräger |
Employees | 16,329 |
Founded | 1889 |
Website | www.draeger.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.